RDS Antibodies

Santa Cruz Biotechnology features a diverse variety of RDS Antibodies for studying Retinal Degeneration Slow (RDS) protein through various research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RDS protein plays a critical role in the structure and function of photoreceptor cells in the retina, contributing to the maintenance of photoreceptor integrity and visual signal transduction. Mutations in the RDS gene are associated with several retinal degenerative diseases, making research in this area essential for understanding the underlying mechanisms of vision loss. Studying RDS protein expression patterns helps researchers identify cellular pathways involved in retinal development and degeneration. Advanced visualization techniques using monoclonal antibodies enable precise localization of RDS protein within cellular compartments. Understanding RDS protein interactions with other molecular components provides valuable insights into retinal cell biology. Investigating RDS expression changes during disease progression helps identify potential therapeutic interventions. Research using RDS monoclonal antibodies from Santa Cruz Biotechnology continues to advance our understanding of retinal biology and potential treatments for vision-related disorders.